Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Asset Utilization Ratio: 2017-2025

Historic Asset Utilization Ratio for Akebia Therapeutics (AKBA) over the last 8 years, with Sep 2025 value amounting to 0.63.

  • Akebia Therapeutics' Asset Utilization Ratio rose 1019.12% to 0.63 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 1019.12%. This contributed to the annual value of 0.69 for FY2024, which is 1970.81% up from last year.
  • According to the latest figures from Q3 2025, Akebia Therapeutics' Asset Utilization Ratio is 0.63, which was up 2.07% from 0.62 recorded in Q2 2025.
  • Over the past 5 years, Akebia Therapeutics' Asset Utilization Ratio peaked at 0.85 during Q1 2023, and registered a low of -0.07 during Q3 2024.
  • For the 3-year period, Akebia Therapeutics' Asset Utilization Ratio averaged around 0.46, with its median value being 0.63 (2025).
  • As far as peak fluctuations go, Akebia Therapeutics' Asset Utilization Ratio plummeted by 108.68% in 2024, and later skyrocketed by 6,154.02% in 2025.
  • Quarterly analysis of 5 years shows Akebia Therapeutics' Asset Utilization Ratio stood at 0.37 in 2021, then skyrocketed by 81.92% to 0.68 in 2022, then tumbled by 93.83% to 0.04 in 2023, then spiked by 1,684.85% to 0.75 in 2024, then surged by 1,019.12% to 0.63 in 2025.
  • Its Asset Utilization Ratio stands at 0.63 for Q3 2025, versus 0.62 for Q2 2025 and 0.70 for Q1 2025.